Dr. Jeffrey L. Vacirca, MD
- Medicare services, 2020
- 4,561
- Part D claims, 2024
- 11
- Publications
- 16
- Clinical trials
- 6
- Hospital affiliations
- 1
- Practice address
- 75 North Country Road, Port Jefferson, NY 11777
- Practice phone
- Call (631) 473-1320
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Vacirca's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jeffrey L. Vacirca is a hematologist and oncologist in Port Jefferson, New York
Dr. Vacirca practices at Mather Hospital in Port Jefferson, New York, part of Northwell Health.
Dr. Vacirca's NPI, 1366446726, was assigned on June 13, 2005. Dr. Vacirca holds New York license 222234.
- NPI
- 1366446726NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7517958762
- NPI enumeration date
- June 13, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (631) 473-1320
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jeffrey L. Vacirca practices at Mather Hospital in Port Jefferson, New York
Dr. Vacirca's primary practice is Mather Hospital, at 75 North Country Road, Port Jefferson, NY 11777 in Suffolk County. The practice phone is (631) 473-1320.
- Mather Hospital75 North Country Road, Port Jefferson, NY 11777 · Suffolk CountyPhone(631) 473-1320
Source: Dmand AI Affiliation Data
Dr. Jeffrey L. Vacirca is affiliated with 3 sites of care and 2 medical groups
Dr. Vacirca's primary practice is Mather Hospital in Port Jefferson, New York, part of Northwell Health. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Vacirca to 1 more group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jeffrey L. Vacirca's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vacirca practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Mather Hospital | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Northwell Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jeffrey L. Vacirca is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Vacirca's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vacirca is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Vacirca
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jeffrey L. Vacirca billed Medicare for 4,561 services in 2020
CMS data shows 4,561 Medicare services from Dr. Vacirca across 29 procedure codes in 2020. Medicare paid $89,608 for them. Every service was in an office.
Dr. Vacirca's Medicare services by type, 2019 to 2020
- 2019
- 2020
- Drugs given in the office
- 2019: 30,0292020: 1,77094%
- Lab and pathology
- 2019: 17,3782020: 1,62991%
- Office and hospital visits
- 2019: 2,4422020: 95661%
- Surgery
- 2019: 1,1992020: 13489%
- Tests and treatments
- 2019: 1,0112020: 7293%
- Other services
- 2019: 2532020: 0100%
Dr. Vacirca compared with the New York median for hematologists and oncologists, 2020
- Dr. Vacirca
- New York median
- Medicare services
- 4,561vs 6686.8 times
- Part D claims
- 11vs 25896% below
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Vacirca's most billed Medicare procedure codes, 2020
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Vacirca?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vacirca and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jeffrey L. Vacirca's patients have a median age of 57
Across all payers, Dmand AI patient panel data puts Dr. Vacirca's median patient age at 57, with 58% women.
Dr. Vacirca's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 57
Patient panel by sex, all payers
- Women58%
- Men42%
Source: Dmand AI Patient Panel Data
Dr. Jeffrey L. Vacirca wrote 11 Medicare Part D claims in 2024
In 2024, Dr. Vacirca wrote 11 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $89 in total drug cost. In 2021, CMS named 12 claims across 1 drug.
Dr. Vacirca's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 122022: 118%
Drugs named by CMS: 1 in 2022, 1 in 2021.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Jeffrey L. Vacirca takes part in Medicare
Dr. Vacirca accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jeffrey L. Vacirca has 16 publications on record
Dmand AI links 16 papers to Dr. Vacirca, published from 2013 to 2020. 2018 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Antiemetics. Dr. Vacirca's most frequent co-authors are Lee S. Schwartzberg, MD, Richy Agajanian, MD and Minsig Choi, MD.
Dr. Vacirca's papers by year, 2013 to 2020
Topics Dr. Vacirca writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Antiemetics
- Breast Neoplasms
- Nausea
- Vomiting
Dr. Vacirca's most frequent co-authors
- Lee S. Schwartzberg, MD4 shared papers
- Richy Agajanian, MD3 shared papers
- Minsig Choi, MD2 shared papers
Recent publications by Dr. Vacirca
See who Dr. Vacirca researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Vacirca works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jeffrey L. Vacirca has worked on 6 clinical trials
Dmand AI links Dr. Vacirca to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Breast Neoplasms.
Clinical trials with Dr. Vacirca by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Vacirca's trials
- Prostatic Neoplasms
- Prostatic Diseases
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Lymphoma, Follicular
Investigators on the most trials with Dr. Vacirca
- Chiledum A. Ahaghotu, MD1 shared trial
- Girish S. Amin, MD1 shared trial
- David Jacob Andorsky, MD1 shared trial
Recent clinical trials with Dr. Vacirca
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer (opens in a new tab)
A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jeffrey L. Vacirca received $255,071 in industry payments from 2016 to 2024
CMS Open Payments shows 116 general payments to Dr. Vacirca from 37 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 72% of the total. Spectrum Pharmaceuticals Inc. paid the most, $226,628. It also lists 1 research payment totaling $2,513 in 2016.
General payments to Dr. Vacirca by program year, 2016 to 2024
General payments to Dr. Vacirca by kind, 2016 to 2024
- Speaker and faculty fees$183,05772%
- Consulting fees$53,57521%
- Travel and lodging$8,0383%
- Food and beverage$7,0563%
- Other$3,3451%
Companies that paid Dr. Vacirca the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Jeffrey L. Vacirca's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jeffrey L. Vacirca
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jeffrey L. Vacirca's NPI number?
Dr. Jeffrey L. Vacirca's NPI number is 1366446726. It was assigned on June 13, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Jeffrey L. Vacirca?
Dr. Jeffrey L. Vacirca is a hematologist and oncologist in Port Jefferson, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Jeffrey L. Vacirca practice?
Dr. Vacirca practices at 75 North Country Road, Port Jefferson, NY 11777. Dr. Vacirca's primary practice is Mather Hospital in Port Jefferson, New York, part of Northwell Health. Dmand AI also links Dr. Vacirca to 1 group practice or clinic, 1 skilled nursing facility and 1 medical group.
What is Dr. Jeffrey L. Vacirca's office phone number?
The practice phone on file for Dr. Vacirca is (631) 473-1320.
What is Dr. Jeffrey L. Vacirca's medical license number?
Dr. Vacirca holds New York license 222234.
Which hospitals is Dr. Jeffrey L. Vacirca affiliated with?
Dr. Vacirca practices at Mather Hospital in Port Jefferson, New York.
What medical group is Dr. Jeffrey L. Vacirca part of?
Dr. Vacirca is linked to New York Cancer & Blood Specialists. Dmand AI links Dr. Vacirca to 1 more medical group.
Does Dr. Jeffrey L. Vacirca accept Medicare?
Yes. CMS data shows Dr. Vacirca billed Medicare for 4,561 services in 2020, and Dr. Vacirca accepts Medicare assignment.
What services does Dr. Jeffrey L. Vacirca bill to Medicare?
In 2020, Dr. Vacirca's most billed Medicare services were injected or infused drug (J0897), care management and other visits (99490) and lab and pathology test (88185).
What drugs does Dr. Jeffrey L. Vacirca prescribe most?
In 2022 Medicare Part D data, Dr. Vacirca's most prescribed drugs by claims were Oxycodone-Acetaminophen.
Show 4 more questionsShow fewer questions
Has Dr. Jeffrey L. Vacirca received payments from drug or device companies?
CMS Open Payments shows $255,071 in general payments to Dr. Vacirca from 37 companies from 2016 to 2024. The largest total came from Spectrum Pharmaceuticals Inc.
How long has Dr. Jeffrey L. Vacirca been practicing?
Dr. Vacirca graduated from medical school in 1998, 28 years ago.
Does Dr. Jeffrey L. Vacirca do research?
Dmand AI links 16 publications to Dr. Vacirca, published from 2013 to 2020. Dr. Vacirca has worked on 6 clinical trials.
Who does Dr. Jeffrey L. Vacirca publish with?
Dr. Vacirca's most frequent co-authors are Lee S. Schwartzberg, MD (4 shared papers), Richy Agajanian, MD (3 shared papers) and Minsig Choi, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card